Paper11030331
Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors.
Lu TT and 6 others. Mol Cell, 2000. Cited by 1,245 papers, by iCite.
Cite this record
ConductScience Library. Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors. Papers, record 11030331. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11030331
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bile Acids and Salts | Major topic |
| Homeostasis | Major topic |
| Receptors, Cytoplasmic and Nuclear | Major topic |
| Animals | |
| Cells, Cultured | |
| Cholesterol | |
| Cholesterol 7-alpha-Hydroxylase | |
| DNA-Binding Proteins | |
| Feedback | |
| Gene Expression Regulation, Enzymologic | |
| Humans | |
| Kidney | |
| Liver X Receptors | |
| Mice | |
| Orphan Nuclear Receptors | |
| Promoter Regions, Genetic | |
| Repressor Proteins | |
| Transcription Factors | |
| Transcription, Genetic | |
| Receptor, Farnesoid X-Activated |
Source PubMed
Cited by520
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,245 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42928767 | Dietary Myo-Inositol Improves Growth Performance and Glycolipid Metabolism in Yellow River Carp (Cyprinus carpio haematopterus) Fed High-Carbohydrate-High-Fat Diets: Involvement of PI3K/Akt and FXR/SHP Pathways. | Aquac Nutr | 2026 | https://conductscience.org/library/papers/42928767 | PubMed |
| 42890784 | Dendrobine's mechanism: alleviating cholesterol metabolism disorders via FXR/LXR modulation in NAFLD mouse livers. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42890784 | PubMed |
| 42825856 | Bile acid signaling in health and disease. | Mol Biomed | 2026 | https://conductscience.org/library/papers/42825856 | PubMed |
| 42819798 | Curcumin-based compounds in non-malignant biliary injury and cholangiocarcinoma: mechanistic insights and translational barriers. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42819798 | PubMed |
| 42813208 | Bile acids as a "new hormone" in aging-related liver disease. | Life Med | 2026 | https://conductscience.org/library/papers/42813208 | PubMed |
| 42754660 | Microbiome-host communication via vaccenic acid modulates LRH-1/NR5A2 activity and ameliorates metabolic liver disease. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/42754660 | PubMed |
| 42643712 | Obeticholic acid as an index farnesoid X receptor scaffold in metabolic dysfunction-associated steatohepatitis: a testable model for efficacy-liability separation and biomarker interpretation. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42643712 | PubMed |
| 42415055 | Dual regulation of bile acids: ameliorating hepatic glycolipid disorders and restoring intestinal health in HFHC-challenged Yellow River carp (Cyprinus carpio L.). | BMC Vet Res | 2026 | https://conductscience.org/library/papers/42415055 | PubMed |
| 42279657 | Physiological Functions of Freshwater Clam Extracts and the Exploration of Their Bioactive Compounds. | Foods | 2026 | https://conductscience.org/library/papers/42279657 | PubMed |
| 42271063 | A first-in-class pulsatile FXR agonist for bile-acid-related liver diseases. | Nature | 2026 | https://conductscience.org/library/papers/42271063 | PubMed |
| 42176224 | NR5A2 controls gene expression and chromatin contacts of essential circadian metabolic genes in the liver. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/42176224 | PubMed |
| 42130294 | LncRNA H19 as a key regulator in biliary atresia: insights into pathogenesis and potential therapeutic targets. | Ann Med | 2026 | https://conductscience.org/library/papers/42130294 | PubMed |
| 41962865 | An artificial intelligence optimized hepatic differentiation unveils NR5A2 and AP-1 transcriptional regulation in hepatic maturation. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41962865 | PubMed |
| 41880103 | Molecular characteristics of apolipoprotein M and its biological functions in kidney diseases. | Mol Cell Biochem | 2026 | https://conductscience.org/library/papers/41880103 | PubMed |
| 41776105 | Dysosma versipellis is associated with cholestatic hepatotoxicity potentially involving FXR-SHP-CYP7A1/BSEP-MRP2 axis disruption: A multi-omics-driven mechanistic investigation based on the toxicological evidence chain (TEC) concept. | J Mol Histol | 2026 | https://conductscience.org/library/papers/41776105 | PubMed |
| 41746003 | Dietary Fiber Regulation of Gut Microbiota and Bile Acid Metabolism in Animals: Implications for Animal Nutrition. | Vet Sci | 2026 | https://conductscience.org/library/papers/41746003 | PubMed |
| 41716273 | Interactions of bile acids and gut microbiota modulate neurological health: a comprehensive review on mechanisms and therapeutic potential of dietary phytochemicals. | Front Microbiol | 2026 | https://conductscience.org/library/papers/41716273 | PubMed |
| 41705236 | Single-cell RNA sequencing and spatial transcriptomic analysis reveal a distinct population of G6PD+ cells with aberrant bile acid metabolism in hepatocellular carcinoma. | Front Immunol | 2026 | https://conductscience.org/library/papers/41705236 | PubMed |
| 41438338 | Enhanced nuclear localization of small heterodimer partner in metabolic dysfunction-associated steatohepatitis. | JHEP Rep | 2026 | https://conductscience.org/library/papers/41438338 | PubMed |
| 41357887 | A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41357887 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CYP7A1 | 1581 | PubTator's text mining | https://conductscience.org/library/genes/1581 | NCBI Gene |
| NR0B2 | 8431 | PubTator's text mining | https://conductscience.org/library/genes/8431 | NCBI Gene |
| NR1H3 | 10062 | PubTator's text mining | https://conductscience.org/library/genes/10062 | NCBI Gene |
| NR1H4 | 9971 | PubTator's text mining | https://conductscience.org/library/genes/9971 | NCBI Gene |
| NR5A2 | 2494 | PubTator's text mining | https://conductscience.org/library/genes/2494 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11030331
GET https://conductscience.org/api/papers/v1/11030331/cited_by?page=2